Indication
Tumor Recurrence
3 clinical trials
3 products
2 drugs
Clinical trial
A Phase 1 Dose-Escalation and Expansion Study of Intratumorally Administered ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and LymphomasStatus: Recruiting, Estimated PCD: 2026-04-30
Product
ONM-501Product
CemiplimabClinical trial
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation in the Early Postoperative Period of Bladder CancerStatus: Recruiting, Estimated PCD: 2023-10-05
Product
IntravesicalClinical trial
Phase II Randomized Trial of Radiotherapy With Concurrent and Adjuvant Pembrolizumab (Keytruda®) Versus Concurrent Chemotherapy in Patients With Advanced/Intermediate-Risk p16+ Head and Neck Squamous Cell Carcinoma (KEYCHAIN)Status: Recruiting, Estimated PCD: 2024-08-01
Drug
mFOLFOX6Drug
Cisplatin